Half of all Medicare Part D covered drugs and nearly half of all Medicare Part B covered drugs (48%) had price increases greater than inflation between July 2019 and July 2020, according to...
All Medicare plans must cover a wide range of prescription drugs, including most drugs in certain protected classes. But Medicare Part D plans must cover all or substantially all drugs in six...
The estimated drug price inflation rate for this year is expected to have a moderate price increase, according to Vizient’s 2022 Pharmacy Market Outlook.
The Vizient Pharmacy Program looked at...
Biogen recently announced that it will reduce the wholesale acquisition cost (WAC) of its Alzheimer’s disease treatment, Aduhelm, in the US by nearly 50 percent.
For a patient of average weight,...
CVS Health recently announced several initiatives to boost affordable healthcare and increase access to medicine for customers.
First, the company named Prem Shah to the newly created role of...
Specialty drugs accounted for 51.4 percent of the net cost in Medicaid and 1.3 percent of utilization in 2020, according to a Magellan Health trend report.
The Medicaid Pharmacy Trend Report looked at...
Eli Lilly and Company recently announced it will lower the list price of Insulin Lispro Injection in the US by another 40 percent.
Effective January 1, 2022, the new list price will be $82.41 for...
PhRMA member companies encourage Congress to abandon old partisan ideas on drug pricing and pursue policies that address patients out of pocket costs, according to a new official letter.
The...
HHS Secretary Xavier Becerra recently released a comprehensive plan to lower prescription drug prices.
The Drug Pricing Plan, part of a broader initiative from Joe Biden’s Executive Order on...
As healthcare begins to reimagine reimbursement and cost, it will be essential to understand the therapies that drive them. By looking into the most prescribed drugs in Medicare—and the...
Launch prices for prescription drugs have doubled since 2005, according to researchers from Duke University’s Fuqua School of Business.
David Ridley, health economist and Fuqua strategy...
Medicare drug spending reached $560 billion from 2016 through 2018, with pharmaceutical marketing accounting for nearly $324 billion in overall spending, according to a GAO study.
Of the 553...
Walmart recently announced the first-ever private brand analog insulin to revolutionize diabetes care management and offer customers significant price savings without compromising overall...
Consumers have saved nearly $30 billion on their prescription drug costs to date with prices found on the GoodRx platform, the company said in a report.
In 2020, GoodRx users saved an average 79...
Biogen’s Alzheimer’s drug, Aduhelm, is expected to increase prescription drug spending and the national health expenditure more than $73 billion by 2028, according to a new Altarum...
JAMA Network Open study found that change in brand-name medication prices for most commercially insured patients correlated with changes in out-of-pocket costs.
In the study, nearly 53.7 percent of...
The Biden Administration recently released new prescription drug policy priorities that focus on addressing the opioid epidemic and reducing drug overdoses.
The priorities provide guideposts to...
Although the treatment prescribed to a patient by a doctor should be best tailored and personalized to the individual, drug affordability and access continues to be a challenge for patients in the...
A recent PhRMA report found that the cost of provider-administered medicines is significantly inflated by various aspects in the pharmaceutical supply chain, including coinsurance, HOPDs, and hospital...
The Supreme Court unanimously ruled that US states can regulate pharmacy benefit managers.
The decision released at the beginning of December ruled in favor of groups arguing on behalf of...
